17
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of Recombinant Human Erythropoietin in the Treatment of Refractory Anemias Without Excess of Blasts in Myelodysplastic Syndromes

, , , , , , , , , & show all
Pages 307-314 | Received 20 May 1993, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Wolf-Karsten Hofmann & Dieter Hoelzer. (1999) Current Clinical Practice: Current Therapeutic Options in Myelodysplastic Syndromes. Hematology 4:2, pages 91-112.
Read now
Per Boyehansen, Milena Penkowa & Hans E. Johnsen. (1998) Hematopoietic Growth Factors for the Treatment of Myelodysplastic Syndromes. Leukemia & Lymphoma 28:5-6, pages 491-500.
Read now
A. Ganser & M. Karthaus. (1997) Clinical Use of Hematopoietic Growth Factors in the Myelodysplastic Syndromes. Leukemia & Lymphoma 26:sup1, pages 13-27.
Read now

Articles from other publishers (6)

John A. Glaspy. 2007. Cytokines in the Genesis and Treatment of Cancer. Cytokines in the Genesis and Treatment of Cancer 449 469 .
John Glaspy. 2006. Erythropoietins and Erythropoiesis. Erythropoietins and Erythropoiesis 163 184 .
Richard S. Stein. (2003) The Role of Erythropoietin in the Anemia of Myelodysplastic Syndrome. Clinical Lymphoma 4, pages S36-S40.
Crossref
Robert Hast, Jonas Wallvik, Annika Folin, Per Bernell & Leif Stenke. (2001) Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment. Leukemia Research 25:1, pages 13-18.
Crossref
Luisa Mantovani, Giuseppe Lentini, Bettina Hentschel, Premaratne Dias Wickramanayake, Markus Loeffler, Volker Diehl & Hans Tesch. (2008) Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony‐stimulating factor and erythropoietin. British Journal of Haematology 109:2, pages 367-375.
Crossref
R. STASI, M. BRUNETTI, S. BUSSA, M. CONFORTI, L. S. MARTIN, M. LA PRESA, M. BIANCHI, A. PARMA & A. PAGANO. (1997) Serum levels of tumour necrosis factor- α predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome . Clinical & Laboratory Haematology 19:3, pages 197-201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.